# BiondVax Pharmaceuticals Ltd. (BVXV)

Source: https://www.quantisnow.com/company/BVXV
Generated: 2026-11-18T22:40:40.747Z

- Ticker: BVXV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2015
- Website: biondvax.com

## About

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

## Latest BVXV news and filings

- 2024-02-14 20:53 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biondvax-pharmaceuticals-ltd-5262661)
- 2024-02-14 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biondvax-pharmaceuticals-ltd-5258801)
- 2024-01-30 21:19 UTC [SEC Form F-3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-biondvax-pharmaceuticals-ltd-5217493)
- 2024-01-24 19:33 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BiondVax Pharmaceuticals Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biondvax-pharmaceuticals-ltd-amendment-5204518)
- 2024-01-18 16:50 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5193521)
- 2024-01-12 12:32 UTC [SEC Form D] [SEC Form D filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-d-filed-by-biondvax-pharmaceuticals-ltd-5185125)
- 2024-01-09 13:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5178176)
- 2024-01-04 21:37 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5170341)
- 2024-01-02 21:54 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BiondVax Pharmaceuticals Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biondvax-pharmaceuticals-ltd-amendment-5161900)
- 2024-01-02 14:58 UTC [SEC Form 424B3] [SEC Form 424B3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biondvax-pharmaceuticals-ltd-5160571)
- 2024-01-02 14:57 UTC [SEC Form 424B3] [SEC Form 424B3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biondvax-pharmaceuticals-ltd-5160569)
- 2024-01-02 14:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5160509)
- 2024-01-02 14:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5160502)
- 2024-01-02 13:24 UTC [SEC Form 424B3] [SEC Form 424B3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biondvax-pharmaceuticals-ltd-5160260)
- 2023-12-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biondvax-pharmaceuticals-ltd-5155468)
- 2023-12-22 14:11 UTC [SEC Form F-1] [SEC Form F-1/A filed by BiondVax Pharmaceuticals Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-f-1a-filed-by-biondvax-pharmaceuticals-ltd-amendment-5152555)
- 2023-12-14 11:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5136705)
- 2023-11-20 15:49 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5095362)
- 2023-11-13 13:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5079070)
- 2023-11-07 11:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5063549)
- 2023-11-03 12:49 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5057638)
- 2023-11-02 17:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-5054476)
- 2023-10-30 20:59 UTC [SEC Form F-1] [SEC Form F-1 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-f-1-filed-by-biondvax-pharmaceuticals-ltd-5044765)
- 2023-10-03 16:38 UTC [SEC Form D] [SEC Form D filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-d-filed-by-biondvax-pharmaceuticals-ltd-5000067)
- 2023-09-22 20:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4984660)
- 2023-09-20 10:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4979424)
- 2023-09-19 19:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4978151)
- 2023-09-19 14:03 UTC [SEC Form 424B5] [SEC Form 424B5 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-biondvax-pharmaceuticals-ltd-4977623)
- 2023-09-11 13:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4963430)
- 2023-09-07 21:27 UTC [SEC Form 424B3] [SEC Form 424B3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-biondvax-pharmaceuticals-ltd-4960240)
- 2023-09-06 16:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4955749)
- 2023-09-06 15:44 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4955687)
- 2023-09-06 10:03 UTC [Market Chatter] [BiondVax Pharma Rebrands as Scinai Immunotherapeutics to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics](https://www.quantisnow.com/insight/biondvax-pharma-rebrands-as-scinai-immunotherapeutics-to-reflect-new-focus-4954412)
- 2023-09-06 10:00 UTC [BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics](https://www.quantisnow.com/insight/biondvax-pharmaceuticals-ltd-rebrands-as-scinai-immunotherapeutics-ltd-to-reflect-4954354)
- 2023-08-28 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biondvax-pharmaceuticals-ltd-4939762)
- 2023-08-24 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4936832)
- 2023-08-23 10:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biondvax-pharmaceuticals-ltd-4930439)
- 2023-08-18 20:16 UTC [SEC Form F-3 filed by BiondVax Pharmaceuticals Ltd.](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-biondvax-pharmaceuticals-ltd-4917803)
- 2023-08-18 14:07 UTC [SEC Form 6-K] [SEC Form 6-K/A filed by BiondVax Pharmaceuticals Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-6-ka-filed-by-biondvax-pharmaceuticals-ltd-amendment-4915656)
- 2023-08-14 10:08 UTC [SEC Form 6-K] [SEC Form 6-K/A filed by BiondVax Pharmaceuticals Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-6-ka-filed-by-biondvax-pharmaceuticals-ltd-amendment-4887796)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BVXV
- Earnings history: https://www.quantisnow.com/earnings/BVXV
- Dividend history: https://www.quantisnow.com/dividends/BVXV
- Insider transactions: https://www.quantisnow.com/insiders/BVXV
- Options chain: https://www.quantisnow.com/options/BVXV
- SEC 8-K filings only: https://www.quantisnow.com/company/BVXV/8-k
- RSS and alerts for BVXV: https://www.quantisnow.com/docs/rss-feeds.md
